![Italian Medicines Agency](https://www.aifa.gov.it/o/aifa-theme/images/aifa/AIFA2021_Col(LR).png)
Safety of medicinal products
AIFA monitors the safe use of medicinal products to ensure the benefit/risk profile of each medicine is positive. Such activity is carried out through the continuous monitoring and evualuation of safety information and, where necessary, through the adoption of regulatory actions in order to promptly protect public health.
AIFA also ensures independent and timely information on the safety of medicinal products by encouraging patients and healthcare professionals to report suspected adverse reactions.
In addition, it promotes active pharmacovigilance programs and studies, in agreement with Regions and according to training and research plans with general practicioners, free choice pediatrician, scientific societies and universities.
24/06/2019
23/09/2019
13/07/2018
20/03/2019
17/05/2019
11/06/2019
26/05/2009
27/04/2009
05/01/2009